CDSCO’s Ban on 35 FDCs: Implications on India’s Drug Approval Landscape
The Central Drugs Standard Control Organisation (CDSCO) has recently announced a ban on the manufacture, sale, and distr...
The Central Drugs Standard Control Organisation (CDSCO) has recently announced a ban on the manufacture, sale, and distr...
In a significant policy shift that could reshape the global pharmaceutical pricing landscape, former U.S. President Dona...
The Indian clinical trials or clinical research market is valued at about USD 1.5 billion and is expected to grow at CAG...
Announced by India’s Prime Minister, Shri Narendra Modi and UK’s Prime Minister, Sir Keir Starmer, India and the Uni...
As the use of Gen AI tools in the workplace continues to proliferate and starts becoming a staple, much like the documen...
Medical education is experiencing a quiet revolution—one that's not taking place in lecture theatres or textbooks, but...
The healthcare sector is currently undergoing a rapid transformation, driven by cutting-edge technologies such as Artifi...